Alzheimer's Disease GWAS Summary Data (Wightman)
Access
Controlled access. Request data access on the AD Knowledge Portal; you need a Synapse account. See How to get the data.
| Where | ID | Access | What you get |
|---|---|---|---|
| Synapse | syn69670625 | Controlled | Files described below |
Other Synapse IDs on this page syn69670626 syn69670630 syn69696846 syn69865816 syn69865824 syn70095142 syn70095143
pip install synapseclient
synapse login
synapse get -r syn69670625Contact
Oluwatosin Olayinka
Source files
The summary statistics are available from the NIAGADS FTP site. The original data (GRCh37, 23andMe individuals only) and a liftover to hg38 are held on the Columbia University (CU) cluster.
Path to SuSiE RSS Fine-mapping Objects
- AD GWAS fine-mapping models (AD Knowledge Portal): syn69670625
- Additional fine-mapping objects: syn69696846
- Top unified loci summary: syn69865824
AD GWAS–xQTL Integration
AD GWAS–xQTL colocalization results (ColocBoost): syn69865816
AD GWAS–xQTL colocalization models: syn69670630
AD colocalization models (all GWAS studies): syn69670626
Integrated AD Gene-Level Summary
AD risk genes prioritized by xQTL + GVC: syn70095142
AD risk genes prioritized by xQTL + TWAS + GVC: syn70095143
Download source
The download source is not public.
File Schema
chromosome: chromosome IDposition: hg38 position (converted from hg19 with liftOver)variant: variant ID in the formchr${chromosome}_${position}_${ref}_${alt}alt: alternative effect alleleref: reference allelez- z-score of the SNP effect sizepvalue: p-value ofbetaN:
Links to GWAS data analysis notebooks
- Summary statistics preprocessing: https://github.com/floutt/brain-xqtl-analysis/blob/main/analysis/Zhang_BU/susie_rss/summary_stat_qc_all.nb.html
Cohorts included in this study
- 1,126,563 individuals = 90,338 (46,613 proxy) cases + 1,036,225 (318,246 proxy) controls
- 77,779 cases + 554,893 controls from Jansen et al.
- 12,559 cases + 481,332 controls not from Jansen et al: Finngen, GRACE, HUNT, BioVU, 23andme, Gothenburg H70 Birth Cohort Studies and Clinical AD from Sweden (Gothenburg), ANMerge.
- Population: US and Europe (UK, Norway, Sweden, Iceland, Finland, Spain)
Supplementary Table 1: A list of the datasets included in the meta-analysis. The UKB data was generated with a continous phenotype so the case-control values are estimates where the number of individuals with phenotype values <1 are controls and >=1 are cases.
| Dataset | Population | Cases | Controls | Imputation panel |
|---|---|---|---|---|
| Included in Jansen et al. (2019) | | | | | ||||
| IGAP* | US & Europe | 21982 | 41944 | 1000G phase 1 |
| UKB (Proxy) | UK | 46613 | 318246 | HRC, 1000G, UK10k |
| DemGene | Norway | 1638 | 6059 | HRC |
| TwinGene | Sweden | 224 | 6321 | HRC |
| STSA | Sweden | 320 | 750 | HRC |
| deCODE (partially included) | Iceland | 7002 | 181573 | deCODE |
| Total | - | 77779 | 554893 | - |
| Not included in Jansen et al. (2019) | ||||
| Finngen* | Finland | 1798 | 72206 | SISu v3 |
| GR@CE | Spain | 4120 | 3289 | HRC |
| HUNT | Norway | 1156 | 7157 | HRC+HUNT |
| BioVU | US | 600 | 36059 | HRC |
| 23andMe | US | 3807 | 359839 | 1000 Genomes Phase 3, UK10K, HRC |
| Gothenburg H70 Birth Cohort Studies and Clinical AD from Sweden (Gothenburg) | Sweden | 712 | 2523 | HRC |
| ANMerge | EUR | 366 | 259 | HRC |
| Total | - | 12559 | 481332 | - |
| Grand total | - | 90,338 | 1,036,225 | |
| *=publically available |